A thorough QT study in the context of an uptitration regimen with selexipag, a selective oral prostacyclin receptor agonist

• Principais autores: Hoch M (Autor), Darpo B (Autor), Remenova T (Autor), Stoltz R (Autor), Zhou M (Autor), Kaufmann P (Autor), Bruderer S (Autor), Dingemanse J (Autor)
• Formato: Livro
• Publicado em: Dove Medical Press, 2014-12-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Matthias Hoch,1 Borje Darpo,2,3 Tatiana Remenova,4 Randall Stoltz,5 Meijian Zhou,2 Priska Kaufmann,1 Shirin Bruderer,1 Jasper Dingemanse1 1Department of Clinical Pharmacology, Actelion Pharmaceuticals Ltd, Allschwil, Switzerland; 2iCardiac Technologies Inc, Rochester, New York, NY, USA; 3Ka...